Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine. In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Bridget A., Wang, Si, Barile, Elisa, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, De, Surya K., Kharagh, Susan Morvaridi, Stebbins, John L., Pandol, Stephen J., Fisher, Paul B., Pellecchia, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941374/
https://www.ncbi.nlm.nih.gov/pubmed/26959746
http://dx.doi.org/10.18632/oncotarget.7931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941374/
https://www.ncbi.nlm.nih.gov/pubmed/26959746
http://dx.doi.org/10.18632/oncotarget.7931

Ejemplares similares